Intellia Therapeutics Inc buy SVB Leerink LLC
Start price
03.03.26
/
50%
€12.16
Target price
03.03.27
€24.79
Performance (%)
-21.30%
Price
07:30
€9.57
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -21.30%. This prediction currently runs until 03.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -4.970% | -4.970% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target raised by Leerink Partners from $27.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat